From: Late term tolerance in head neck cancer patients irradiated in the IMRT era
Parameters | RON G2-4 | Mucosal ulcer | PEG | Xerostomia | Tracheostomy | Laryngectomy | Loss of taste | Others | All events/affected patients |
---|---|---|---|---|---|---|---|---|---|
Diagnosis (n), % persistent | lat oro (6/149), 1% | lat oro (9/149), <1% | lat oro (7/149), 0% | lat oro (1/149), 0% | glottic (1/59), 2% | SGL (2/31), 6% | lat oro (1/149), <1% | lat oro (1/149), 0% | |
cent oro (5/96), 0% | centr oro (3/96), 1% | centr oro (8/96), 3% | hypo (1/69), 0% | hypo (1/69), 1% | hypo (1/69), 0% | centr oro (3/96), 0% | |||
OCC (10/111), 3% | OCC (8/111), 0% | OCC (4/111), 1% | NPC (3/51), 6% | parotid (2/36), 6% | OCC (1/111), <1% | ||||
hypo (4/69), 0% | hypo (5/69), 1% | (sino-)nasal (5/50), 5% | |||||||
NPC (1/51), 0% | |||||||||
All | 21/356, 6% G2-4 | 28/593, 5% | 28/606, 5% | 5/476, 1% | 2/159, 1% | 2/159, 1% | 4/512, 2% | 7/707, 1% | 101 events in 92/707 patients, 13% |
Persistent G3/4 effects (n) | 1% (5) | <1% (2) | <1% (5) | <1% (3) | 1% (2) | 1% (2) | <1% (3) | <1% (3) | 4% (25 events in 25/707 patients) |